HUBB vs REPL · P/E 28, rev $5.63B vs $825.7M cap
Hubbell Inc (HUBB) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported HUBB revenue for 2024-12-31 was $5.63B. Net income was $783.5M. Revenue was up 4.8% from 2023-12-31 to 2024-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
REPL does not have a complete income-statement cache yet.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the HUBB and REPL stock pages for the full models.
Not investment advice.